[1] Schillaci G, Verdecchia P, Porcellati C, et al.Continuous relation between left ventricular mass and cardiovascular risk in essential hypertension[J].Hypertension, 2000, 35( 2):580-586. [2] Wilson EM, Diwan A, Spinale FG, et al.Duality of innate stress responses in cardiac injury, repair, and remodeling[J].J Mol Cell Cardiol, 2004, 37( 4):801-811. [3] Mann DL.Inflammatory mediators and the failing heart: past, present, and the foreseeable future[J].Circ Res, 2002, 91( 11):988-998. [4] Werner N, Nickenig G, Laufs U.Pleiotropic effects of HMG-CoA reductase inhibitors[J].Basic Res Cardiol, 2002, 97( 3):105-116. [5] 田建伟, 赵连友, 王士雯, 等.阿伐他汀对幼年大鼠心肌成纤维细胞增殖和胶原合成的影响及其意义[J]. 中华医学杂志, 2003, 83( 2):118-122. [6] Zhang J, Cheng X, Liao YH, et al.Simvastatin regulates myocardial cytokine expression and improves ventricular remodeling in rats after acute myocardial infarction[J]. Cardiovasc Drugs Ther, 2005, 19( 1):13-21. [7] Wallace CK, Stetson SJ, Kucuker SA, et al.Simvastatin decreases myocardial tumor necrosis factor alpha content in heart transplant recipients[J].J Heart Lung Transplant, 2005, 24( 1):46-51. [8] Li JM, Gall NP, Grieve DJ, et al.Activation of NADPH oxidase during progression of cardiac hypertrophy to failure[J].Hypertension, 2002, 40( 4):477-484. [9] Wright G, Singh IS, Hasday JD, et al.Endotoxin stressresponse in cardiomyocytes:NF-κB activation and tumor necrosis factor-αexpression[J].Am J Physiol Heart Circ Physiol, 2002, 282( 3):H872-879. [10] 唐惠芳, 吴书林, 邓春玉, 等.辛伐他汀减轻舒张功能不全大鼠心肌线粒体损伤[J].中国临床药理学与治疗学, 2009, 14( 7):780-784. [11] 吴旭斌, 周胜华, 林英忠, 等.罗格列酮联合阿托伐他汀对高胆固醇血症兔主动脉斑块面积和TNF-α的影响[J].中国临床药理学与治疗学, 2009, 14( 3): 255-260. [12] 赵连友, 陈永清, 郑强荪, 等.辛伐他汀对自发性高血压大鼠左心室肥厚影响与蛋白激酶B 表达的关系[J].中华医学杂志, 2005, 85( 19):1344-1347. [13] 王彦珍, 罗建东.活性氧介导内皮素-1 诱导的培养新生大鼠心肌细胞肥大[J].生理学报, 2004, 56( 3): 403-406. [14] Delbosc S, Cristol JP, Descomps B, et al.Simvastatin prevents angiotensin II-induced cardiac alteration and oxidative stress[J].Hypertension, 2002, 40( 2):142-147. [15] Wassmann S, Laufs U, Muller K, et al.Cellular antioxidant effects of atorvastatin in vitro and in vivo[J].Arterioscler Thromb Vasc Biol, 2002, 22( 2):300-305. [16] Touyz RM, Schiffrin EL.Reactive oxygen species in vascular biology:implications in hypertension[J].Histochem Cell Biol, 2004, 122( 4):339-352. [17] Ndengele MM, Muscoli C, Wang ZQ, et al.Superoxide potentiates NF-kappaB activation and modulates endotoxininduced cytokine production in alveolar macrophages[J]. Shock, 2005, 23( 2):186-193. [18] Ali MH, Schlidt SA, Chandel NS, et al.Endothelial permeability and IL-6 production during hypoxia:role of ROS in signal transduction[J].Am J Phy siol, 1999, 277( 5 Pt 1):L1057-1065. [19] Khadour FH, Panas D, Ferdinandy P, et al.Enhanced NO and superoxide generation in dysfunctional hearts from endotoxemic rats[J].Am J Physiol Heart Circ Physiol, 2002, 283( 3):H1108-H1115. [20] Laufs U, Kilter H, Konkol C, et al.Impact of HMG CoA reductase inhibition on small GTPases in the heart[J]. Cardiovasc Res, 2002, 53( 4):911-920. [21] Maack C, Kartes T, Kilter H, et al.Oxygen free radical release in human failing myocardium is associated with increased activity of rac1-GTPase and represents a target for statin treatment[J].Circulation, 2003, 108( 13):1567-1574. |